Annual Meeting 2022: NFL’s Brandon Bolden Joins as AACR Ambassador
In 2015, NFL running back Brandon Bolden was having an incredible season with the New England Patriots. That year,...
Category: Meetings
In 2015, NFL running back Brandon Bolden was having an incredible season with the New England Patriots. That year,...
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
For the first time since 2019, the American Association for Cancer Research (AACR) Annual Meeting is set to return...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), along with other...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...